LYB
NYSE · Chemicals
Lyondellbasell Indu-Cl A
$77.19
+1.18 (+1.55%)
Financial Highlights (FY 2026)
Revenue
39.01B
Net Income
1.32B
Gross Margin
11.3%
Profit Margin
3.4%
Rev Growth
-4.4%
D/E Ratio
0.89
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 11.3% | 11.3% | 40.1% | 40.1% |
| Operating Margin | 5.2% | 4.7% | 11.7% | 12.6% |
| Profit Margin | 3.4% | 3.2% | 13.4% | 14.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 39.01B | 40.82B | 7.30B | 8.08B |
| Gross Profit | 4.42B | 4.62B | 2.92B | 3.24B |
| Operating Income | 2.03B | 1.91B | 854.25M | 1.02B |
| Net Income | 1.32B | 1.25B | 974.42M | 1.18B |
| Gross Margin | 11.3% | 11.3% | 40.1% | 40.1% |
| Operating Margin | 5.2% | 4.7% | 11.7% | 12.6% |
| Profit Margin | 3.4% | 3.2% | 13.4% | 14.7% |
| Rev Growth | -4.4% | -4.4% | +6.8% | +9.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.20B | 4.20B | 1.19B | 1.20B |
| Total Equity | 4.70B | 4.70B | 7.44B | 7.52B |
| D/E Ratio | 0.89 | 0.89 | 0.16 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 3.57B | 3.55B | 1.33B | 1.49B |
| Free Cash Flow | — | — | 1.05B | 1.41B |